FIELD: medicine. SUBSTANCE: method involves removing xerotic conglomerate from cornea surface. The cornea is preliminarily cut at the boundary separating transparent and pathologically changed tissue. The internal surface is separated from the transparent layers by means of YAG laser. EFFECT: reduced risk of cornea injuries.
